Combined intravenous/intraarterial compared with Intraarterial recombinant tissue plasminogen activator in acute ischemic stroke: Propensity score analysis

被引：0
|
作者：
Zaidat, OO
Welter, E
Love, TE
Tarr, RW
Sunshine, JL
Landis, DMD
Selman, WR
Enterline, DS
Smith, TP
Alexander, MJ
机构：
来源：
JOURNAL OF NEUROSURGERY | 2004年 / 100卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A181 / A181
页数：1
相关论文
共 50 条
  • [21] INTRAARTERIAL VERSUS INTRAVENOUS TISSUE-TYPE PLASMINOGEN-ACTIVATOR TREATMENT IN EXPERIMENTAL STROKE - RESPONSE
    ZABRAMSKI, JM
    HAMILTON, MG
    STROKE, 1994, 25 (08) : 1699 - 1700
  • [22] Intravenous Thrombolysis With Low-Dose Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
    Loh, Pei Kee
    Sharma, Vijay K.
    STROKE, 2010, 41 (03) : E164 - E164
  • [23] Hemorrhage, Recanalization, and Clinical Outcomes for Combined Intravenous and Intraarterial Thrombolysis for Acute Ischemic Stroke
    Janjua, Nazli
    Melkumova, Emiliya
    Akrem, Shamrez
    Hussein, Haitham
    Ramirez-Abreu, Darwin
    Poleshuck, Rebecca
    McIntyre, Sherene
    Gropen, Toby
    Morales, Ximena
    Qureshi, Adnan
    NEUROLOGY, 2011, 76 (09) : A152 - A152
  • [24] Comparison of Primary Intraarterial Thrombectomy and Intravenous Thrombolysis Bridging with Intraarterial Thrombectomy for Acute Ischemic Stroke
    Jeong, Hyeseon
    Song, Hee-Jung
    Kwon, Hyun Jo
    Ko, Hyun Song
    Kang, Chang Woo
    Kim, Jei
    STROKE, 2013, 44 (02)
  • [25] CIRCADIAN VARIATION OF THE EFFICACY OF INTRAVENOUS RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR IN PATIENTS WITH ACUTE ISCHEMIC STROKE
    Kim, J.
    Lee, S.
    SLEEP, 2018, 41 : A23 - A24
  • [26] Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: Initial Israeli experience
    Schwammenthal, Y
    Drescher, MJ
    Merzeliak, O
    Tsabari, R
    Bruk, B
    Feibel, M
    Hoffman, C
    Bakon, M
    Rotstein, Z
    Chapman, J
    Tanne, D
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2004, 6 (02): : 70 - 74
  • [27] CIRCADIAN VARIATION OF EFFICACY OF INTRAVENOUS RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR IN PATIENTS WITH ACUTE ISCHEMIC STROKE
    Lee, S.
    Kim, J. H.
    INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 116 - 116
  • [28] Intravenous thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke in a patient treated with rivaroxaban
    van Hooff, Robbert-Jan
    Nieboer, Koenraad
    De Smedt, Ann
    Yperzeele, Laetitia
    Jochmans, Kristin
    De Keyser, Jacques
    Brouns, Raf
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2014, 122 : 133 - 134
  • [29] Intravenous recombinant tissue plasminogen activator therapy for ischemic stroke patients over 80 years old: a propensity score matched analysis from the Fukuoka Stroke Registry
    Matsuo, R.
    Kamouchi, M.
    Hata, J.
    Wakisaka, Y.
    Kuroda, J.
    Ago, T.
    Kitazono, T.
    CEREBROVASCULAR DISEASES, 2014, 37 : 149 - 149
  • [30] LOW-DOSE INTRAVENOUS RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR MAY NOT BRING BETTER EFFICACY AND SAFETY OUTCOME FOR CHINESE PATIENTS WITH ACUTE ISCHEMIC STROKE: A PROPENSITY SCORE ANALYSIS
    Xu, J.
    Fang, K.
    Xie, Y.
    Dong, Q.
    Dong, Y.
    INTERNATIONAL JOURNAL OF STROKE, 2022, 17 (3_SUPPL) : 157 - 159
12345